Assessment of the Susceptibility of Clinical Gram-Negative and Gram-Positive Bacterial Strains to Fosfomycin and Significance of This Antibiotic in Infection Treatment.
Gram-positive and Gram-negative strains
IV fosfomycin
agar dilution method
in vitro susceptibility
multidrug-resistant strains
Journal
Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317
Informations de publication
Date de publication:
30 Nov 2022
30 Nov 2022
Historique:
received:
10
10
2022
revised:
24
11
2022
accepted:
29
11
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
24
12
2022
Statut:
epublish
Résumé
Multidrug resistance of bacteria has prompted intensive development work on new medicines, but also the search for effective options among the oldest antibiotics. Although intravenous fosfomycin (IVFOS) seems to be an interesting proposal, the recommended agar dilution method for susceptibility determination poses a major problem in routine diagnostic testing. As a consequence, there is a lack of comprehensive data on the frequency of isolation of susceptible or resistant strains. This fact triggered the disposition of EUCAST concerning the revision of IVFOS breakpoints (BPs), including withdrawal of BPs for
Identifiants
pubmed: 36558775
pii: pathogens11121441
doi: 10.3390/pathogens11121441
pmc: PMC9786176
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Wrocław Medical University
ID : SUBZ.D230.22.026
Références
RSC Adv. 2019 Dec 19;9(72):42204-42218
pubmed: 35548698
J Paediatr Child Health. 2020 Jun;56(6):864-872
pubmed: 32294306
Infection. 1992 Nov-Dec;20(6):350-4
pubmed: 1293056
Indian J Crit Care Med. 2021 Sep;25(9):1055-1058
pubmed: 34963727
Clin Microbiol Infect. 2020 Dec 5;:
pubmed: 33285277
Rev Esp Quimioter. 2019 May;32 Suppl 1:45-54
pubmed: 31131592
Infect Drug Resist. 2019 Jul 09;12:2005-2013
pubmed: 31372008
Expert Rev Anti Infect Ther. 2020 Jul;18(7):657-668
pubmed: 32397774
Antimicrob Agents Chemother. 2013 Nov;57(11):5701-3
pubmed: 23939889
Braz J Infect Dis. 2015 May-Jun;19(3):319-23
pubmed: 25626961
Antibiotics (Basel). 2022 Jan 25;11(2):
pubmed: 35203756
Antimicrob Agents Chemother. 2020 Oct 20;64(11):
pubmed: 32868330
Chemotherapy. 1977;23 Suppl 1:416-22
pubmed: 318977
Antibiotics (Basel). 2022 May 27;11(6):
pubmed: 35740130
Clin Microbiol Infect. 2017 Jun;23(6):363-372
pubmed: 27956267
Infect Dis Rep. 2022 Aug 18;14(4):621-634
pubmed: 36005269
J Antimicrob Chemother. 2019 May 1;74(5):1430-1437
pubmed: 30796442
Access Microbiol. 2019 Jul 01;1(5):e000031
pubmed: 32974526
J Med Microbiol. 2019 May;68(5):711-719
pubmed: 30994430
J Clin Microbiol. 2012 Dec;50(12):3877-80
pubmed: 22993175
Front Microbiol. 2020 Jun 26;11:1290
pubmed: 32670230
Infection. 2019 Oct;47(5):827-836
pubmed: 31190298
Microorganisms. 2020 Feb 20;8(2):
pubmed: 32093299
Clin Microbiol Infect. 2022 Apr;28(4):521-547
pubmed: 34923128
J Bacteriol. 2009 Nov;191(22):6968-74
pubmed: 19734311
J Antimicrob Chemother. 2021 Nov 22;76(Suppl 4):iv23-iv37
pubmed: 34849997
Chemotherapy. 1995 Jan-Feb;41(1):45-9
pubmed: 7875021
Indian J Urol. 2017 Apr-Jun;33(2):149-154
pubmed: 28469304
Arch Dis Child. 2003 Jun;88(6):512-6
pubmed: 12765918
J Infect Dis. 2019 Jul 19;220(4):666-676
pubmed: 31099835
Expert Rev Anti Infect Ther. 2022 Jan;20(1):33-43
pubmed: 34030567
Clin Infect Dis. 2022 Aug 17;:
pubmed: 35974429
Antibiotics (Basel). 2017 Oct 31;6(4):
pubmed: 29088073
Yonsei Med J. 2016 Mar;57(2):283-90
pubmed: 26847277
J Antimicrob Chemother. 2020 Aug 1;75(8):2282-2290
pubmed: 32355950
Rev Esp Quimioter. 2019 May;32 Suppl 1:30-36
pubmed: 31131590
Pathogens. 2021 Feb 19;10(2):
pubmed: 33669789
Clin Microbiol Infect. 2000 Sep;6(9):509-15
pubmed: 11168187
J Antimicrob Chemother. 2015 Nov;70(11):3042-50
pubmed: 26209311
Pharmaceuticals (Basel). 2021 Feb 25;14(3):
pubmed: 33668905
J Clin Med. 2021 Mar 04;10(5):
pubmed: 33806604
J Antimicrob Chemother. 2018 Sep 1;73(9):2380-2387
pubmed: 29982660
Front Microbiol. 2019 Jan 07;9:3195
pubmed: 30666237
Diagn Microbiol Infect Dis. 2019 Feb;93(2):143-146
pubmed: 30236530
Pathogens. 2021 Apr 23;10(5):
pubmed: 33922754
J Cyst Fibros. 2003 Mar;2(1):19-24
pubmed: 15463841
Can J Infect Dis Med Microbiol. 2018 Jun 25;2018:8912039
pubmed: 30046362
J Antimicrob Chemother. 2017 Jul 1;72(7):1985-1990
pubmed: 28444224
J Antimicrob Chemother. 2018 Mar 1;73(suppl_3):iii2-iii78
pubmed: 29514274
J Glob Antimicrob Resist. 2021 Jun;25:26-34
pubmed: 33667703
J Infect Dev Ctries. 2020 Apr 30;14(4):394-397
pubmed: 32379717
Drugs. 2017 Jun;77(9):941-950
pubmed: 28456943
Emerg Infect Dis. 2017 Nov;23(11):1902-1904
pubmed: 29048285
Int J Antimicrob Agents. 2014 Jan;43(1):52-9
pubmed: 24183799
Lancet Glob Health. 2017 Nov;5(11):e1066-e1068
pubmed: 29025624
Expert Opin Investig Drugs. 2009 Jul;18(7):921-44
pubmed: 19548851
Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):153-60
pubmed: 18336741
Int Immunopharmacol. 2002 Mar;2(4):511-8
pubmed: 11962730
Sci Rep. 2022 Jan 7;12(1):230
pubmed: 34997148
J Antibiot (Tokyo). 2015 Sep;68(9):551-5
pubmed: 25805069
Int J Antimicrob Agents. 2016 Apr;47(4):269-85
pubmed: 27013000
Antimicrob Agents Chemother. 2020 May 21;64(6):
pubmed: 32253214
Antimicrob Agents Chemother. 2019 May 24;63(6):
pubmed: 30910903
J Antimicrob Chemother. 2001 Feb;47(2):141-6
pubmed: 11157896
PLoS One. 2015 Aug 07;10(8):e0135269
pubmed: 26252888
BMC Urol. 2017 Apr 26;17(1):33
pubmed: 28446177
Antimicrob Agents Chemother. 2015 Apr;59(4):2029-36
pubmed: 25605365
Afr Health Sci. 2019 Sep;19(3):2400-2406
pubmed: 32127810
J Antimicrob Chemother. 2019 Jan 1;74(1):177-181
pubmed: 30376073
Ann Clin Microbiol Antimicrob. 2020 Jan 9;19(1):1
pubmed: 31918737
Rev Esp Quimioter. 2019 May;32 Suppl 1:8-18
pubmed: 31131587
Bone Res. 2022 Aug 12;10(1):53
pubmed: 35961964